The bill, which prohibits the Alabama Board of Medical Examiners and the Medical Licensure Commission of Alabama from taking action, passed unanimously in the state House and Legislature.
Off-label use refers to prescribing an approved drug for an unapproved disease or condition, administering it in a different form or giving it in a different dose.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.